Increased risk of all-cause mortality associated with domperidone use in Parkinson's patients: a population-based cohort study in the UK.
Marina SimeonovaFrank de VriesSander PouwelsJohanna H M DriessenHubert G M LeufkensSuzanne M CadaretteAndrea Michelle BurdenPublished in: British journal of clinical pharmacology (2018)
Current use of domperidone was associated with a two-fold increased mortality risk in PD patients, as compared to PD patients that never used domperidone. The risk is highest in the first month of use and does not appear to be attributable to PD alone.